Sterling Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$339K Buy
+14,087
New +$368K 0.08% 91
2024
Q4
$203K Sell
7,649
-975
-11% -$26.4K 0.07% 105
2024
Q3
$250K Buy
8,624
+680
+9% +$19.8K 0.09% 101
2024
Q2
$222K Sell
7,944
-705
-8% -$19.4K 0.11% 97
2024
Q1
$240K Hold
8,649
– – 0.12% 87
2023
Q4
$249K Buy
+8,649
New +$261K 0.14% 80

Other funds holding PFE

Sterling Wealth Management's PFE Position: Q2 2026 in Review

Sterling Wealth Management opened a new position in Pfizer (PFE) in Q2 2026: 14,087 shares worth $339K. The stake represents 0.08% of the portfolio and ranks #91 among its holdings. This is a return to the name: Sterling Wealth Management previously reported a position in PFE as recently as Q4 2024.

Sterling Wealth Management first reported a position in PFE in Q4 2023 and has held it in 6 quarters since. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sterling Wealth Management held 14,087 shares of Pfizer worth $339K as of Q2 2026.
  • Pfizer was a new Sterling Wealth Management position in Q2 2026.
  • Pfizer made up 0.08% of Sterling Wealth Management's portfolio in Q2 2026, its #91 holding.
  • Sterling Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 6 quarters since.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sterling Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.